Skip to main content
Ocugen, Inc. logo

Ocugen, Inc. — Investor Relations & Filings

Ticker · OCGN ISIN · US43358V1098 LEI · 549300JVNUI9CXWJLR09 US Manufacturing
Open in API
Filings indexed 848 across all filing types
Latest filing 2018-02-21 Director's Dealing
Country US United States of America
Listing US OCGN

About Ocugen, Inc.

https://ocugen.com/

Ocugen, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel gene therapies, cell therapies, and vaccines. The company's primary mission is to develop treatments for blindness diseases, leveraging its first-in-class modifier gene therapy platform. This platform represents a potential paradigm shift in treating inherited retinal diseases by aiming to address multiple genetic mutations with a single product. In addition to its focus on ocular health, Ocugen is also advancing a pipeline that includes vaccines for infectious diseases. The company is dedicated to addressing significant unmet medical needs and providing innovative therapeutic options for patients with debilitating conditions.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2018-02-21 English
SCHEDULE 13G
Major Shareholding Notification
2018-01-26 English
424B5
Capital/Financing Update Classification · 95% confidence The document is a prospectus supplement filed pursuant to Rule 424(b)(5) related to a common stock offering. It includes detailed information about the offering, underwriting, risk factors, use of proceeds, and other related disclosures typical of a securities offering document. The presence of terms like 'Prospectus Supplement', 'Offering Price', 'Underwriting Discount', and references to the Securities and Exchange Commission and Nasdaq confirm this is a capital raising document. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. The document is lengthy (15,000 characters) and contains substantive information about the offering, not just an announcement or a brief notice, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is CAP with high confidence.
2018-01-24 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is used for current reports to announce major events that shareholders should know about. The content describes an underwriting agreement for a registered direct offering of common stock, including details about the offering size, price, and related agreements. It also references a press release about the offering. This is an update on the company's financing activities, specifically a capital raise. The document is not a full financial report, earnings release, or management discussion, but rather a disclosure of a financing transaction. Therefore, it fits best under the category 'Capital/Financing Update' (CAP). The document length and detail support this classification with high confidence.
2018-01-23 English
424B3
Capital/Financing Update Classification · 95% confidence The document is a prospectus filed pursuant to Rule 424(b)(3) with the SEC, describing a shelf registration for offering up to $50 million of various securities including common stock, preferred stock, warrants, debt securities, units, and rights. It includes detailed information about the securities, risk factors, use of proceeds, and legal matters. The document references the Securities Act of 1933 and the Exchange Act, and it is dated March 30, 2017. This type of document is a registration prospectus related to capital raising activities, not an annual report, earnings release, or other financial report. It is a detailed disclosure document for investors about a securities offering. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full prospectus text, not just an announcement or link to a report, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2018-01-22 English
SABBY 13G-A HSGX 1.08.18
Major Shareholding Notification
2018-01-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.